Meningococcal Vaccines Market Growth, Future Scope, Challenges, Opportunities 2030
According to MRFR analysis, Meningococcal Vaccines Market has a demand for USD 172 Million. Further, the global estimated supply in 2019 is expected to be 203 Million doses. Despite broad and effective commitment from the global health community in meningitis A (MENA) vaccination in the meningitis belt, low manufacturing capacity and high prices across other meningococcal vaccine types have hindered access to these vaccines over the past several years. A more in-depth knowledge will benefit addressing these long-standing access issues and the development of the WHO global roadmap for overcoming meningitis by 2030. This is expected to set goals for disease control and vaccination for meningococcal meningitis on a global level. Regional Analysis Need for meningococcal vaccines is characterized by significant use outside of routine immunization: subnational use, immunization of special risk groups such as military personnel or travelers, private market use, or recommended but not
Comments
Post a Comment